Amgen (AMGN) EPS (Basic) (2009 - 2026)
Amgen's quarterly EPS (Basic) came in at $3.37 in Q1 2026, up 4.66% year-on-year from $3.22 in Q1 2025, and up 36.44% quarter-over-quarter from $2.47 in Q4 2025.
Amgen has reported EPS (Basic) for 18 years, with the latest figure at $3.37 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 4.66% year-over-year to $3.37; the trailing twelve-month figure through Mar 2026 stood at $14.48 (up 31.04% YoY), and the FY2025 full-year result was $14.33, up 88.06% from the prior year.
- EPS (Basic) for Q1 2026 stood at $3.37, up from $2.47 in the prior quarter.
- The five-year high for EPS (Basic) was $5.98 in Q3 2025, with the low at -$0.21 in Q1 2024.
- Average EPS (Basic) over 5 years is $2.95, with a median of $2.69 recorded in 2022.
- Year-over-year, EPS (Basic) slumped 103.95% in 2024 and surged 1633.33% in 2025.
- Tracing AMGN's EPS (Basic) over 5 years: stood at $3.02 in 2022, then sank by 52.32% to $1.44 in 2023, then slipped by 18.75% to $1.17 in 2024, then jumped by 111.11% to $2.47 in 2025, then jumped by 36.44% to $3.37 in 2026.
- The last three EPS (Basic) figures came in at $3.37 (Q1 2026), $2.47 (Q4 2025), and $5.98 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 8.27 |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.17 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 0.39 |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -1.72 |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 3.37 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.63 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 0.48 |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.31 |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.37 |
| Dec 31, 2025 | 2.47 |
| Sep 30, 2025 | 5.98 |
| Jun 30, 2025 | 2.66 |
| Mar 31, 2025 | 3.22 |
| Dec 31, 2024 | 1.17 |
| Sep 30, 2024 | 5.27 |
| Jun 30, 2024 | 1.39 |
| Mar 31, 2024 | -0.21 |
| Dec 31, 2023 | 1.44 |
| Sep 30, 2023 | 3.23 |
| Jun 30, 2023 | 2.58 |
| Mar 31, 2023 | 5.32 |
| Dec 31, 2022 | 3.02 |
| Sep 30, 2022 | 4.01 |
| Jun 30, 2022 | 2.46 |
| Mar 31, 2022 | 2.69 |
| Dec 31, 2021 | 3.36 |
| Sep 30, 2021 | 3.32 |
| Jun 30, 2021 | 0.81 |
| Mar 31, 2021 | 2.85 |
| Dec 31, 2020 | 2.78 |
| Sep 30, 2020 | 3.45 |
| Jun 30, 2020 | 3.07 |
| Mar 31, 2020 | 3.09 |
| Dec 31, 2019 | 2.87 |
| Sep 30, 2019 | 3.29 |
| Jun 30, 2019 | 3.59 |
| Mar 31, 2019 | 3.20 |
| Dec 31, 2018 | 3.04 |
| Sep 30, 2018 | 2.88 |
| Jun 30, 2018 | 3.50 |
| Mar 31, 2018 | 3.27 |
| Dec 31, 2017 | -5.89 |
| Sep 30, 2017 | 2.78 |
| Jun 30, 2017 | 2.93 |
| Mar 31, 2017 | 2.81 |
| Dec 31, 2016 | 2.61 |
| Sep 30, 2016 | 2.70 |
| Jun 30, 2016 | 2.49 |
| Mar 31, 2016 | 2.52 |
| Dec 31, 2015 | 2.39 |
| Sep 30, 2015 | 2.46 |
| Jun 30, 2015 | 2.18 |
| Mar 31, 2015 | 2.13 |
| Dec 31, 2014 | 1.70 |
| Sep 30, 2014 | 1.63 |
| Jun 30, 2014 | 2.04 |
| Mar 31, 2014 | 1.42 |
| Dec 31, 2013 | 1.35 |
| Sep 30, 2013 | 1.81 |
| Jun 30, 2013 | 1.67 |
| Mar 31, 2013 | 1.91 |
| Dec 31, 2012 | 1.03 |
| Sep 30, 2012 | 1.44 |
| Jun 30, 2012 | 1.63 |
| Mar 31, 2012 | 1.50 |
| Dec 31, 2011 | 1.09 |
| Sep 30, 2011 | 0.50 |
| Jun 30, 2011 | 1.26 |
| Mar 31, 2011 | 1.21 |
| Dec 31, 2010 | 1.09 |
| Sep 30, 2010 | 1.29 |
| Jun 30, 2010 | 1.25 |
| Mar 31, 2010 | 1.19 |
| Dec 31, 2009 | 0.93 |
| Sep 30, 2009 | 1.36 |
| Jun 30, 2009 | 1.25 |
| Mar 31, 2009 | 0.99 |